A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/12/2002	US20020187139 Composition and method for lactose hydrolysis
12/12/2002	US20020187136 Administering shuffled lytic enzymes, chimeric lytic enzymes, or holin enzymes, produced by infecting a bacterium causing the infection with a bacteriophage specific for said bacteria
12/12/2002	US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002	US20020187131 Conjugating an antigen to a molecule targeted to an endocytic receptor on the dendritic cell, such as DEC-205. The molecule targeted may be a natural ligand to the receptor or an antibody thereto.
12/12/2002	US20020187124 Asialocytokines and treatment of liver disease
12/12/2002	US20020187123 Therapeutic compositions and methods for the inhibition of angiogenesis
12/12/2002	US20020187105 Polymer combinations that result in stabilized aerosols for gene delivery to the lungs
12/12/2002	US20020187104 Containing an effective amount of an effervescent agent.
12/12/2002	DE10147056A1 New pentapeptides containing 5-membered ring in the peptide chain, useful as apoptosis inducing antitumor agents, for treating neurological and/or inflammatory disorders or in tumor diagnosis
12/12/2002	DE10125893A1 Medicament used for inhibiting vascular smooth muscle cell growth, especially for combating cardiovascular disease, contains gut enriched Kruppel-like factor related nucleotide sequence or corresponding polypeptide
12/12/2002	DE10125882A1 Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicines containing an effector of the glutathione metabolism together with alpha-lipoic acid in the treatment of diabetes mellitus
12/12/2002	CA2830887A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002	CA2464511A1 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
12/12/2002	CA2457959A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002	CA2452865A1 Conditioned cell culture media and uses thereof
12/12/2002	CA2449890A1 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002	CA2449837A1 Implantation of biological pacemaker that is molecularly determined
12/12/2002	CA2449825A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2449686A1 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	CA2449671A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
12/12/2002	CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002	CA2449487A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002	CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449466A1 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
12/12/2002	CA2449426A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	CA2449320A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	CA2449290A1 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002	CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449135A1 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002	CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002	CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448591A1 T cell induced tissue repair and regeneration
12/12/2002	CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002	CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002	CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002	CA2448379A1 Calorically dense liquid oral supplement
12/12/2002	CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002	CA2448256A1 Novel human proteins, polynucleotides encoding them and methods of using the same
12/12/2002	CA2448073A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002	CA2448066A1 Chimeric alphavirus replicon particles
12/12/2002	CA2448051A1 Methods and compositions for modulating ace-2 activity
12/12/2002	CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2446929A1 Orally administering parathyroid hormone and calcitonin
12/12/2002	CA2446610A1 20 human secreted proteins
12/12/2002	CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002	CA2446160A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
12/12/2002	CA2442743A1 Human secreted proteins
12/12/2002	CA2438571A1 Novel proteins and nucleic acids encoding same
12/12/2002	CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002	CA2418088A1 Numb protein expression inhibitors by musashi 1
12/11/2002	EP1264887A1 Novel armadillo repeat-containing protein alex1
12/11/2002	EP1264884A1 Method of controlling telomere length
12/11/2002	EP1264844A1 Modified bdnf
12/11/2002	EP1264843A2 38554, 57301 and 58324, Human organic ion transporters and uses therefor
12/11/2002	EP1264842A1 Novel proteins and novel genes encoding the same
12/11/2002	EP1264841A1 DNA encoding a mutant peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1), detection methods and test kits therefor
12/11/2002	EP1264840A1 Long lasting fusion peptide inhibitors of viral infection
12/11/2002	EP1264837A1 Conjugation-stabilized polypeptide compositions
12/11/2002	EP1264601A2 Treatment of a coronary condition by delivery of therapeutics to the pericardial space
12/11/2002	EP1264599A1 TNF-derived peptides for use in treating oedema
12/11/2002	EP1264598A1 Altering an immune response by influencing the interaction of LAIR with its ligand
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1264183A2 Diagnosis and treatment of vascular dementia
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263968A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/11/2002	EP1263955A2 Polypeptides and nucleic acids encoding same
12/11/2002	EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/11/2002	EP1263953A2 Novel family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof
12/11/2002	EP1263951A2 Transcription activator of the cited family
12/11/2002	EP1263950A2 Seven-transmembrane proteins/g-protein coupled receptors
12/11/2002	EP1263949A2 Secretory polypeptides and corresponding polynucleotides
12/11/2002	EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/11/2002	EP1263947A2 Nucleic acid sensor molecules
12/11/2002	EP1263944A2 Nucleic acids, proteins, and antibodies
12/11/2002	EP1263943A1 Protein c derivatives
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263939A1 18477, a human protein kinase and uses therefor
12/11/2002	EP1263933A2 Treatment for bone disorders
12/11/2002	EP1263884A1 Process for the preparation of micronised collagen, and its therapeutic applications
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263789A2 Antibody inhibiting the binding between gp120 and dc-sign and screening methods
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263785A2 Mutated il-13 molecules and their uses
12/11/2002	EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
12/11/2002	EP1263783A2 Maurocalcine, analogues thereof and their therapeutical uses
12/11/2002	EP1263779A1 Self antigen vaccines for treating b cell lymphomas and other cancers
12/11/2002	EP1263778A1 Peptide inhibitors of lfa-1/icam-1 interaction
12/11/2002	EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells
12/11/2002	EP1263775A1 Hla binding peptides and their uses
12/11/2002	EP1263774A2 Gamma-secretase inhibitors
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
12/11/2002	EP1263473A2 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
12/11/2002	EP1263471A2 Antimicrobial compounds and formulations

1 ... 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 ... 3163